English | Español
Patient Daily | Mar 16, 2026

Hansoh reports positive Phase 3 results for obesity drug olatorepatide in China
Patient Daily | Mar 16, 2026

FDA biologics director Vinay Prasad to depart in April, analysts predict impact on biotech
Patient Daily | Mar 16, 2026

Roche reports breast cancer drug giredestrant fails key Phase 3 trial
Patient Daily | Mar 16, 2026

Five therapies show progress in multiple myeloma treatment landscape
Patient Daily | Mar 16, 2026

Novo Nordisk to sell GLP-1 drugs through Hims & Hers after ending legal dispute
Patient Daily | Mar 16, 2026

FDA advisory committee to review two AstraZeneca cancer drugs in April meeting
Patient Daily | Mar 16, 2026

Xenon to seek approval of first-in-class epilepsy drug after exceeding Phase 3 expectations
Patient Daily | Mar 16, 2026

Terasaki Institute and Keck Graduate Institute announce biomedical research partnership

Trending
+ Regulatory
Patient Daily | Mar 30, 2026

Freedom Foundation CEO Meeks on 340B: 'The program has morphed into a veritable ATM for hospitals'
+ Regulatory
A. D. Brady | Mar 30, 2026

Consumer Choice Advocate: RFK Jr. helped ‘dubious claims gain credibility in courtrooms’
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Alliance for Consumers releases update on trial law firm political donations
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Biopharma mergers and acquisitions reach $46.8 billion in first quarter of 2026